Oncotype DX Breast Recurrence Score® test

Clarity beyond the initial diagnosis It’s personal.

It’s personal.
The Oncotype DX Breast Recurrence Score® test uses your unique tumor tissue to provide personalized insights on whether your tumor may respond to chemotherapy.
Reference: Paik et al. N Engl J Med. 2004. https://www.nejm.org/doi/full/10.1056/NEJMoa041588

It’s insightful.
Your test results will help you understand how likely it is that cancer will return somewhere else in your body and whether you may or may not benefit from chemotherapy.
Reference: Sparano et al. N Engl J Med. 2018. https://www.nejm.org/doi/full/10.1056/NEJMoa1804710

It’s proven
The Oncotype DX Breast Recurrence Score test is the only genomic test proven to predict if you may benefit from chemotherapy.
Reference: NCCN Guidelines Insights: Breast Cancer, version 1.2026. https://www.nccn.org/